But I still wonder, was Mistake #2 really a mistake? Or was this a special situation, where bankruptcy was narrowly avoided? Or is emergency capital easy to find in the biotech industry? I don't want to ride a company straight into bankruptcy in the future just because of this one experience. Can anyone offer some insight on this?Based on what you said, I wouldn't consider it a mistake, just bad luck. You had decided that your investment thesis didn't work so you got out. I would call it a mistake if you bailed just because the price dropped. You need to look at the decision not its outcome. (A more complicated assessment requires knowing whether you could have predicted the recovery. I don't know much about biotech and I'm not familiar with that company so I don't know if there were signs that the company was ok even in the darkest days.)
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra